Meeder Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History

Meeder Advisory Services’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.02M	Buy	8,015 +1	+0%	+$480	0.15%	93
2026 Q1	$3.94M	Buy	8,014 +314	+4%	+$170K	0.16%	84
2025 Q4	$4.46M	Buy	7,700 +277	+4%	+$157K	0.19%	76
2025 Q3	$3.6M	Buy	7,423 +919	+14%	+$428K	0.17%	93
2025 Q2	$2.64M	Sell	6,504 -792	-11%	-$331K	0.14%	117
2025 Q1	$3.63M	Buy	7,296 +212	+3%	+$115K	0.22%	73
2024 Q4	$3.69M	Sell	7,084 -181	-2%	-$99.5K	0.23%	67
2024 Q3	$4.49M	Sell	7,265 -145	-2%	-$85.8K	0.29%	54
2024 Q2	$4.1M	Buy	7,410 +2,005	+37%	+$1.15M	0.29%	52
2024 Q1	$3.14M	Buy	5,405 +386	+8%	+$217K	0.32%	49
2023 Q4	$2.66M	Sell	5,019 -238	-5%	-$115K	0.31%	54
2023 Q3	$2.66M	Sell	5,257 -633	-11%	-$337K	0.33%	48
2023 Q2	$3.07M	Sell	5,890 -563	-9%	-$304K	0.33%	48
2023 Q1	$3.72M	Buy	6,453 +390	+6%	+$220K	0.43%	38
2022 Q4	$3.34M	Buy	+6,063	New	+$3.21M	0.42%	42

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Meeder Advisory Services's TMO Position: Q2 2026 in Review

Meeder Advisory Services increased its Thermo Fisher Scientific (TMO) stake by 0.01% in Q2 2026, buying an estimated $480 and bringing the position to 8,015 shares worth $4.02M. The position accounts for 0.15% of the portfolio, ranked #93.

Meeder Advisory Services first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.49M in Q3 2024. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Meeder Advisory Services held 8,015 shares of Thermo Fisher Scientific worth $4.02M as of Q2 2026.
Meeder Advisory Services bought 1 Thermo Fisher Scientific share in Q2 2026, an estimated $480.
Thermo Fisher Scientific made up 0.15% of Meeder Advisory Services's portfolio in Q2 2026, its #93 holding.
Meeder Advisory Services first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
Meeder Advisory Services's Thermo Fisher Scientific position peaked at $4.49M in Q3 2024.
2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.